Indivior Pharmaceuticals

Indivior Pharmaceuticals

INDV· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +188.7% in FY2025

Joe Ciaffoni is the CEO of Indivior Pharmaceuticals and was paid $18.5M in FY2025 (Dec).

Pay$100 in the stock at the end of FY24 → $289
CEO pay is from each Indivior Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1Joe CiaffoniFY2025
  2. 2Pat BarryFY2025
  3. 3Christian HeidbrederFY2025
  4. 4Richard SimkinFY2025
  5. 5Ryan PreblickFY2025
  6. 6Jeff BurrisFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Indivior Pharmaceuticals paid its 7 named executives $41.9M in total in FY2025 (Dec). CEO Joe Ciaffoni was paid $18.5M of that.

Name
Joe CiaffoniChief Executive OfficerNot disclosedNot disclosed
Pat BarryChief Commercial OfficerNot disclosedNot disclosed
Christian HeidbrederChief Scientific Officer
Richard SimkinFormer Chief Commercial Officer
Ryan PreblickChief Financial Officer
Jeff BurrisChief Legal Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers20

See all

The FY2025 (Dec) proxy of Indivior Pharmaceuticals names 20 peer companies for pay. Among Indivior Pharmaceuticals and these peers, CEO pay was 4th highest of 12 and total shareholder return was 5th highest of 12.

4th highest of 12in Indivior Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$6.9M$33.2M

5th highest of 12in Indivior Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$13$321

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

  1. Pay
    Indivior Pharmaceuticals CFO pay rose 57% to $3.6M. The stock rose 189% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Indivior Pharmaceuticals Division head pay rose 26% to $4.0M. The stock rose 189% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Indivior Pharmaceuticals Division head pay fell 12% to $3.2M. The stock fell 19% in FY2024 (Dec).
    DEF 14A
  4. Pay
    Indivior Pharmaceuticals Former CEO pay fell 17% to $3.2M. The stock rose 189% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Indivior Pharmaceuticals Former CEO pay fell 12% to $3.9M. The stock fell 19% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Indivior Pharmaceuticals General counsel pay rose 79% to $3.5M. The stock rose 189% in FY2025 (Dec).
    DEF 14A
  7. Pay
    Indivior Pharmaceuticals General counsel pay fell 11% to $2.0M. The stock fell 19% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Indivior Pharmaceuticals Chief Scientific Officer pay rose 67% to $4.2M. The stock rose 189% in FY2025 (Dec).
    DEF 14A
  9. Pay
    Indivior Pharmaceuticals Chief Scientific Officer pay fell 12% to $2.5M. The stock fell 19% in FY2024 (Dec).
    DEF 14A

Filings3

See all
Proxy statementDEF 14AMar 27, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Annual report10-KMar 3, 2025FY2024
For the press:Download CSVDownload PNGHow to use our data